Eli Lilly
LLY
#13
Rank
C$1.268 T
Marketcap
C$1,415
Share price
-1.85%
Change (1 day)
21.93%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

P/S ratio for Eli Lilly (LLY)

P/S ratio as of December 2025 (TTM): 15.3

According to Eli Lilly's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 38.1. At the end of 2025 the company had a P/S ratio of 10.9.

P/S ratio history for Eli Lilly from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
202510.9-30.09%
202415.6-3.58%
202316.233.15%
202212.230.53%
20219.3341.77%
20206.5816.73%
20195.642.71%
20185.4935.01%
20174.076.28%
20163.83-18.01%
20154.6719.45%
20143.9158.51%
20132.46-1.49%
20122.5026.27%
20111.9813.23%
20101.75-6.89%
20091.88-16.37%
20082.25-30.87%
20073.25-13.5%
20063.76-13.95%
20054.37-5.79%
20044.64-26.2%
20036.28-2.38%
20026.43-15.82%
20017.64

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Bristol-Myers Squibb
BMY
2.20-85.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3.92-74.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.29-65.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.33-84.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.51-83.59%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
2.31-84.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
6.78-55.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.09-66.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4.51-70.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AstraZeneca
AZN
4.80-68.62%๐Ÿ‡ฌ๐Ÿ‡ง UK